Pages

Friday, April 29, 2022

Health Care Reform Articles - April 29, 2022


Maine lawmakers examine dispute between MaineHealth and Anthem

April 28, 2022

On Thursday, lawmakers on the legislature's Health Coverage, Insurance and Financial Services Committee took up the dispute between MaineHealth and Anthem. MaineHealth recently announced Maine Medical Center would no longer be an in-network provider for Anthem as of 2023. The consequences of such a move for consumers have raised alarms. Committee members are trying to decide what actions to take in their role of providing oversight of both the state employees' health plan and the Maine's Bureau of Insurance, which is conducting a review of Anthem.

The committee first heard from MaineHealth CEO Andrew Mueller, who reiterated the points he made earlier this month. Mueller said Anthem owes MaineHealth $70 million in back payments and is withholding an additional $13 million a year from Maine Medical Center over disputed payments. It comes at a time, he said, when the health system has already taken a financial hit from the COVID pandemic.

"We feel like we're down and wounded, and we're getting kicked pretty hard at the worst possible time," Mueller said.

Mueller also accused Anthem of making midyear changes to coverage, including prohibiting providers from billing for more than one procedure per day per patient. He gave the example of a cancer patient who had a hysterectomy and a lymph node biopsy the same day, but coverage of the biopsy was denied. When the president of Anthem in Maine, Denise McDunough, spoke to the committee, she said that the insurance company is scrutinizing claims to ensure providers are billing appropriately. And in 2018, she said, Anthem discovered overcharges which resulted in MaineHealth refunding $20 million to patients.

"The real issue between Anthem and MaineHealth is the result of Anthem having discovered that MaineHealth is materially over-charging Anthem and its members," McDunough said.

The two sides provided a "he said/she said" view of the situation, and comments from Maine's Bureau of Insurance shed little light. The Bureau is conducting a market review of Anthem, but Acting Superintendent Tim Schott said findings are confidential until the review is complete — which will likely take several months. But he said Maine law does have protections for consumers.

"There is a right for continuity of care," Schott said, which requires insurance coverage for consumers to continue for at least 60 days after a contract is terminated. But that's of little consolation to groups insured by Anthem, including 68,000 active and retired teachers and their families and more than 25,000 state employees. If Maine Medical Center is not a part of Anthem's network, patients who receive non-emergency care at the hospital would likely be billed at higher rates.

Anya Trundy of Maine's Department of Administrative and Financial Services said state employees' current health plan with Anthem runs through next June, and there isn't enough time to switch insurers before then.

"This termination should be avoided at all costs," Trundy said.

While lawmakers and regulators are urging MaineHealth and Anthem to reach a resolution, testimony during a public comment period was mostly directed at Anthem. A spokesperson from the American Hospital Association said issues with the insurer aren't unique to Maine. And Jeff Austin of the Maine Hospital Association said they're not unique to MaineHealth. As of the end of last year, he said, Anthem owed hospitals in the state $350 million.

"It's become easier to do the brain surgery than to collect payment for brain surgery," Austin said.

Independent providers also expressed frustrations with Anthem. Jay Mullen is CEO of Blue Water Health, a physician-owned medical group that staffs emergency rooms. He said currently 25% of its Anthem payments are past due, and the insurer uses policies that harm patients who have legitimate concerns that send them to emergency rooms.

"When, after the thorough ED evaluation, including x-rays, EKG's, lab work, etcetera, it turns out they have a non-emergent conditions," Mullen said. "Anthem is denying coverage or reducing payment for that ED visit."

Others took a broader view of the situation and urged lawmakers to look beyond just resolving the current dispute between MaineHealth and Anthem. Karen Foster of the group Maine AllCare suggested it's time to seriously consider universal health care, which she said would be simpler and better for consumers.

"I haven't heard anyone say why don't we take a look at the forest instead of focusing on the trees?" Foster said.

It's unclear what the outcome of the legislative meeting will be. After several hours of testimony, committee chair Democratic Senator Heather Sanborn said there was a lot of information to digest and there are no specific next steps.

https://www.mainepublic.org/health/2022-04-28/maine-lawmakers-examine-dispute-between-mainehealth-and-anthem 

 Editor's Note -

If you click on the link above, you can listen to the audio of this story - if you'd like.

For a more detailed discussion of the benefits of universal health care in Maine - and some of the reasons for going that route, see my testimony at the same hearing, as orally delivered to the committee (short version) and submitted in writing for the Committee archives (longer version.) 

You will find some ideas in this testimony you haven't thought about and may find useful.

😇

You can read my testimony below.

- SPC

Oral Testimony - HCIFS Committee of the Maine Legislature - Takeaways from HCIFS hearing on 4-28-2022
By Philip Caper, M.D.


What we have all witnessed today is the dynamics of a failed market at work. Our flawed and ill-advised market-based for-profit and competition driven system, codified in the ACA, is behaving, not as it was intended to do, but as it was designed to do.

This is not a failure of Anthem or of Maine Health.  Everybody is just doing their job, as they see it.  What you’re seeing is market-failure at work, and conflict created by a misalignment of incentives and of missions among the players.

Competitive markets do not, have not and will not ever work in health care, for reasons I detail in my submitted written testimony.

What was missing in this hearing, so far, is any in-depth discussion of the effects of this profit-seeking competitive  behavior on “consumers” - AKA “patients”.  It’s all about the money!

Who is at fault is this mess?   When you put the fox in charge of the chicken coop, and the chickens begin to disappear, you don’t blame the fox for being a fox. You have to ask “who put the fox in charge?”

This is a failure of public policy. No other wealthy country in the world has relied on a market-based, competitive system to control healthcare costs and protect the quality of care, and assure access medical care.

 I hope today’s hearing has demonstrated some of the reasons why that is the case, and has helped you to understand why the problems this hearing was intended to address are crying out for systemic and transformational changes.  

Tinkering with the ACA will never produce the kind of changes that are needed.

Anything less is just kicking the can down the road - and guarantees that we will be back next year, the year after that and a decade from now -talking about the same problems.

This committee - and the legislature - has to think outside the box. That box is the belief that our for-profit, competitive and market-based system of health care is the right policy. What’ needed is transformational change.

It’s time to realize that the grand American experiment in market-based, profit-seeking and competitive health care has failed.

What we need is to return to a system based upon patient welfare - not money - sound health planning and cooperation among non-profit sources of financing, and health care delivery entities (including doctors) and patients.

Dirigo!

 Maine can lead the way in showing how it can be done. That is absolutely do-able.  80-90 percent of the problems you heard described today would go away if this were done. The problem is not one of financial resources - we’re now spending too much as is, and could fund universal coverage out of the waste in what we’re now spending.

This problem is almost entirely a political one, and the legislature is the key to solving it. After all, our state and federal legislatures put the fox in charge of the chicken coop in the first place. Now, the state and federal legislatures are going to have to take responsibility for the mess, and fix the situation, as hard as that is going to be.

 Activation of PL 391, that became law thats to the action of this Committee is one path that can be taken to start the process of getting this done.

Once universal health care in Maine is a reality, I believe that the only remaining question the beneficiaries of this change (all of the people of Maine) would ask is “Why did it take so long?”

 

Written Testimony

Testimony before the Health Care, Insurance and Financial Services Committee of the Maine Legislature
by Philip Caper, M.D.


Thursday, April 28, 2022

Good morning chairs Sanborne and Tepler, and members  of the Committee. I am Doctor Philip Caper, and live in Brooklin, Maine. I am an internist, and have been an outspoken advocate of reforming our broken health care system, and replacing it with a publicly funded, universal system as is the norm in all other wealthy democracies throughout the world. I believe a so-called single payer system is the fairest, most efficient and effective way to achieve that goal.

I was not born a single payer advocate. But I have repeatedly returned to single payer as the best solution to the many problems of our health care system throughout my over 50 year long career as a college and medical student, resident and fellow in medical training. During my career, I have served as a student and teacher at some of the country’s most prestigious universities, a clinician and researcher at some of our country’s best medical centers, a public healthcare policy-maker at the highest levels of the US government.

I have also been an entrepreneur and was the founder, chairman and CEO of a health care software and data company that was recognized by the Wall Street Journal in their 1992 centennial edition as one on the 100 most innovative companies in the world.

I have lived in Maine for twenty years, andI am also a founding Board member of Maine AllCare, a non-profit group that advocates for a non-profit universal system of health care financing for the state of Maine.

Last year, after ten years of service on the MAC Board, I was termed out, and am speaking today as an individual Mainer.

The healthcare system in Maine, and throughout the US, are by far the most expensive of any in the world. Yet, health care costs continue to rise, almost a third of Mainers and other Americans remain either un-insured or under-insured. Medical costs are a leading cause of bankruptcy in America - a situation that is not tolerated and for the most part is non-existent in other wealthy countries. Despite this, the results of our system are mediocre at best by most measurements. The US is the only wealthy country in the world where the life-expectancy is actually decreasing.

You’ve heard all of this before. Yet our health care system continues to deteriorate. What you may not know is that the healthcare system in the United States (including Maine) is the the only one in the world that relies as heavily on a for-profit, market and employment-based system of private insurance for financing, implemented by national or international for-profit investor owned publicly or private equity financed companies. That is the most internationally distinguishing characteristic of our health care system. Such companies have one over-riding mission - to create wealth for their owners. It is time to declare that experiment a failure.

In fact, the profit-seeking ethic of these companies has become so wide-spread throughout the health care system that it has infected even nominally non-profit- companies such as Maine Medical Center and Maine General Hospital in Augusta. Several years ago, Maine General Hospital (nominally a non-profit hospital) shut down their diabetes clinic because — it was not profitable.

During my over 50 year career in health care, I have watched the transition of the system from one almost completely dominated by  non-profit insurance companies, such as Blue Cross/Blue Shield of Maine (before its acquisition by Anthem), and non-profit community based hospitals (such as Maine Medical Center), granted tax-exemption in exchange for community service.

The dispute between Anthem Insurance Company and Maine Health that has generated this hearing is the inevitable result of profit- seeking behavior between these two Goliath-like entities. Our for-profit health care system, based on the theology of the marketplace, importance of “consumer” choice and the supremacy of shareholder (or stakeholder) value. (A similar dispute happened a decade or so ago between the Tufts Health Plan and the Massachusetts General Hospital in Massachusetts. It was eventually resolved mostly in favor of MGH, after they ran a successful campaign of fear aimed at patients enrolled in the Tufts plan who were threatened of being unable to use MGH in the future.)

These conflicts of interest are inevitable in a healthcare system based on business ethics, market principles, and competition among health care providers and insurance companies.  From the point of view of investors in the health care industry, healthcare is a great business opportunity - a belief validated by the high return on their investments since enactment of the Affordable Care Act. Absent major intervention by government, those returns will remain high into the future, and the consequences of those high returns - high costs to the purchasers of such services (all of us), high gaps in coverage and poor to mediocre results) will continue.

That is so for one over-riding reason - the “consumers” (aka “patients”) have no power!

Economists George Akerlof,  Michael Spence and Joseph Stiglitz won the Nobel Prize in Economics in 2001 for their analyses of markets with asymmetric information. In their study of the market for used cars (Selling Lemons), they demonstrated that in markets where the sellers have much more information than the buyers, quality suffers and those markets eventually become corrupt.

I can think of no markets with a greater asymmetry of information than health care. It is almost impossible for a “consumer” to predict the cost, quality or appropriateness  of the health care they receive.

In order to work well (or even to work at all), markets must satisfy three basic requirements. “Consumers” (aka patients) must be able to afford the product (healthcare products and services in this case), be able to make a free non-coerced choice of what and whether to buy the product and accurate information about both the quality and price of the product.  In healthcare, none of these three requirements are is fully met.


For these reasons alone, no other wealthy country in the world has tried to implement a market-based system of health care such as the one created by the Affordable Care Act, much less one carried out implemented by corporate entities focused on return-on investment, as in Maine and the rest of the US. In fact, the American healthcare system is the object of ridicule and an example of how not to run a healthcare system throughout the developed world.

It is as if one were to build a house built on an unstable foundation that is constantly shifting. As cracks appear in the walls, leaks appear in the roof, and leaks appear in the plumbing  and short circuits appear in the electrical circuits, attempts to fix the problem by patching the walls, patching the leaks in the roof and patchwork fixes are attempted to repair the plumbing and electrical system problems, they inevitably re-appear - until the shifting foundation is stabilized. These patchwork fixes only succeed in kicking the can down the road.

That is a good analogy for attempts to fix our broken health care system without eliminating its for-profit market-based foundation. We must replace it with a system that is based on sound health planning and cooperation instead of competition among health care “providers” such as hospitals and doctors.

In today’s system, even the most well intended doctors, nurses and other health care workers are constantly swimming against the tide. Such workers have increasingly become cogs in a corporate machine that is always pressuring them to put institutional profits, not patients, first.  It is the moral injury produced by this conflict that accounts for the widespread dis-satisfaction and eventual burn-out of health care workers. It is not just the paperwork.

The problems of our healthcare system are overwhelmingly political.  They are not due to a shortage of money or even of real resources such as doctors, nurses, (and other health care workers), facilities and equipment - although there is plenty misallocation of those resources. The barriers to change are to be found in mis-placed ideology (the theology of the marketplace and of competitive marketplace incentives) and a lack of political will to get the job done.

Who are the villains in this story, and who is to blame for our inability to fix it. Every other wealthy country in the world has succeeded in having a much more well functioning healthcare system than ours, using differing paths to do so.  

It’s a little like putting the fox in charge of the chicken coop, and then blaming the fox when the chickens begin disappearing. This is not a failure of the profit-seeking companies we have put in charge of the healthcare system. For-profit companies play a role in many other countries. It is not capitalism per-se that is the problem.  It is capitalism-run-amok that is the problem. It is the American predilection for unfettered capitalism and unregulated markets that are the problem. It is the American knee jerk predilection for deregulation and low taxes, no matter how much good they do that is the problem.

The problem is a corrupt and ineffective public policy, encouraged by our insistence that we consider corporations to be people, and consider money to be the equivalent of speech. Most of this corruption is perfectly legal - although there is plenty of waste, fraud and abuse that is not so legal in our healthcare system). (Read “License to Steal” by Malcolm Sparrow.)

It is also result of a political system that is more responsive to political contributions than it is to the public’s preferences, to the dominance of corporate contributions in the funding of political campaigns, and to a public that continues to vote for office-holders that don’t carry out their campaign promises.

If we are ever to dig ourselves out of the deep hole we have dug by coupling market theology with free reign for profit-seeking corporations throughout the system, and could replace health care as a profitable commodity with health care as a public good as have most of the world’s wealthy democracies, there will be only one more question.

“Why did it take us so long”? 



Thursday, April 28, 2022

Health Care Reform Articles - April 28, 2022

 

The Anthem-MaineMed dispute highlights the complexity of our health system

by The Editorial Board - Bangor Daily News - April 25,  2022

Health care funding — hospital billing and insurance claims payments — is complex and often confusing. Both lack needed transparency for patients.

A dispute between Maine’s largest health care insurer and largest health care provider threatens to leave thousands of people without access to needed care. It also highlights the dysfunction of our health care industry and its finances.

Earlier this month, Maine Medical Center in Portland announced that it would essentially drop in-network coverage for patients with Anthem Blue Cross and Blue Shield insurance beginning in January. These patients may still be able to be treated at the hospital but they may need prior approval and would pay higher rates. Emergency room services for Anthem subscribers will still be covered.

Insurance companies and health care providers often negotiate rates and terms for services and treatments. It is unusual for the negotiations — and disagreements like these — to spill into public view, showcasing the discord between the two largest players in Maine’s health care system.

Discussions of patient care are largely lost in the debate.

MaineHealth, the parent company of Maine Medical Center, said that Anthem owes it more than $70 million for services over the last three years. Anthem has also been withholding payments totaling around $13 million a year, MaineHealth officials said. Other MaineHealth providers and offices will continue to accept Anthem insurance.

Anthem has faced similar complaints and disputes in several other states. Last month, the state of Georgia fined the company $5 million after officials there said Anthem misled patients about what hospitals and providers were available through its network.

Anthem has countered the Maine Medical Center claims by saying that the hospital is inflating prices, which raises insurance and health care costs for all patients. For example, the company told the Portland Press Herald that the hospital charged Anthem patients $136 for a bag of saline that should have cost $2, and overcharged for tissue used in breast reconstructive surgeries for cancer patients. The hospital said it needed more information to assess these claims.

Gov. Janet Mills has urged the hospital and Anthem to resolve the dispute. The governor’s sister is an executive at MaineHealth. Anthem provides insurance coverage to state employees.

This dispute comes as calls for more transparency around charges for hospital services and decisions about insurance coverage intensify. Under the Affordable Care Act, insurance companies must devote most of their premium charges to patient care, not administration, salaries and profit. The ACA, which has been codified into Maine law, also includes many procedures, such as mental health services, pregnancy care and preventative services, that must be covered by insurance.

Hospital billing, on the other hand, is not subject to similar government rules and lacks much transparency. New laws, and a new Office of Affordable Health Care, created last year by the Legislature, may help increase transparency. The office, which was created by legislation sponsored by Senate President Troy Jackson, is charged with reviewing the state’s health care system and developing proposals to “improve coordination, efficiency and quality of the health care system.”

In addition, the Legislature’s Health Coverage, Insurance and Financial Services Committee will soon hold a meeting with representatives from Maine Medical Center and Anthem to discuss this situation.

“These types of disputes and ongoing issues are why we need to continue the work to reform our health care system in Maine and across the country,” Jackson told the BDN editorial board. “The system is complicated from tricky insurance claims and difficult-to-read medical bills to the pricing of prescription drugs, all of which give industry players the cover to trade blame over outrageous prices while patients are left grappling with the cost of treatment and care.

“The Office of Affordable Health Care has a role to play to reform our system here in Maine in the long run,” the Senate president added. “However, in the meantime, the Legislature’s Health Coverage, Insurance and Financial Services will hold a hearing in the coming weeks to give both MaineHealth and Anthem a forum to present their side of the dispute. At the end of the day, the two parties must resolve the issue quickly for the sake of Maine people who are stuck in the crossfire.”

This dispute, and others that are likely to follow, lend support to the notion of a single payer healthcare system. Under such a system, one payer — often the government — would cover the cost of health care, typically for a large population. Medicare and Medicaid are single-payer systems. Both have much lower administrative costs than private insurance plans.

Health care funding — hospital billing and insurance claims payments — is complex and often confusing. Both lack needed transparency for patients.

We hope that Anthem and Maine Medical Center will reach an agreement before January so thousands of patients won’t have their medical care disrupted or delayed. But this standoff should prompt lawmakers to take a much harder look at making the entire health care system better, more transparent and centered on patients’ needs.

https://bangordailynews.com/2022/04/25/opinion/editorials/the-anthem-maine-med-dispute-highlights-complexity-of-our-health-system/

Our health care system is broken and we need fundamental change 

by Ted Sussman - Bangor Daily News - April 25, 2022

The BDN Opinion section operates independently and does not set newsroom policies or contribute to reporting or editing articles elsewhere in the newspaper or on bangordailynews.com.

Ted Sussman has been a physician in Houlton for more than 40 years and joined the Maine AllCare board in 2021. He is a past governor of the Maine chapter of the American College of Physicians, and also served on the Maine Health Access Foundation board.

As a Mainer, a physician and a Maine AllCare board member, I was disappointed to learn that Maine Health Care Action will be unable to gather the needed signatures to get a universal health care Resolve on the ballot in 2023, as reported by the BDN on April 13.

Maine AllCare has advocated for universal, publicly funded health care for Maine since 2010. We hoped that the effort would give Maine voters the chance to send a clear message: Our health care system is broken, and we need fundamental change.

I believe that Maine Health Care Action may have succeeded if not for the COVID-19 pandemic, which all but eliminated in-person events and made it very difficult to gather signatures, despite the valiant efforts of dozens of volunteers. And I share their belief that this effort is not finished.

It’s true that campaigns in other states to establish universal health care, through ballot initiatives and legislation, have so far been unsuccessful — the April 13 article mentions Vermont. But the real failure is not a lack of resources, as is often stated. In the U.S., we already spend far more on health care than other developed countries — 16.8 percent of GDP compared with Germany’s 11.7 percent, the next highest — yet have worse outcomes.

Nor is it lack of a workable model. A 2019 fiscal study by the Maine Center for Economic Policy shows one model for how universal health care in Maine would cover everyone and save money.

The April 13 article notes that health care reform is a “perennial subject” in the Legislature, and this is true. But I believe this indicates the need for fundamental reform, not an argument against it. Fixing our dysfunctional health care system requires big changes, not tinkering around the edges, and mustering the political will to make those changes is a steep climb.

The article misses other parts of the picture as well. Describing the consensus report of a 2018 legislative task force on health care reform as “tepid,” for one.

One of the outcomes of this task force was the formation of a Joint Standing Committee on Health Care, Insurance and Financial Services, which has been instrumental in keeping a legislative focus on health care reform. Among the reforms considered by the Legislature was LD 1045, An Act to Support Universal Health Care, which was passed and became law in 2021. This new law provides one pathway to achieving universal health care in Maine, contingent on action by Congress.

At Maine AllCare, we know there is strong public support for remaking our health care system to be fair, affordable and economically sound. Our tens of thousands of supporters and the countless stories of people struggling to get health care without suffering financial hardship show us how deeply Mainers understand this need.

Look at any movement for social or political change, and you’ll see that it takes years, sometimes decades, for a sound idea to gain traction and become reality. I believe that universal, publicly funded health care is one of those ideas, and that we are gaining traction, bit by bit. Maine Health Care Action’s suspension of signature-gathering is far from the end of the story.

https://bangordailynews.com/2022/04/25/opinion/opinion-contributor/our-healthcare-system-is-broken-joam40zk0w/

Anthem president: We’re working to protect health care affordability

The insurer is committed to coming back to the negotiating table, and it hopes MaineHealth will join them, Denise McDonough says.

 by Denise McDonough - Portland Press Herald - April 26, 2022
 
All of us at Anthem Blue Cross and Blue Shield in Maine are deeply committed to providing our 300,000 members access to high quality, outcomes-driven health care. We believe MaineHealth shares these goals. Where our two perspectives diverge, however, is that our work centers on ensuring that care is affordable.

The reality is, health care costs in Maine are high – some of the highest in the country – and if we are not vigilant, they’ll continue to climb higher. An objective 2019 study by the University of Pennsylvania ranked Maine as having the fourth highest health care cost burden for working families in America, and a 2020 study by the Rand Corp. showed prices paid to hospitals in Maine by private insurers are 252 percent of what Medicare would have paid for the same services at the same facilities.

The result? Maine can be such an expensive state for health care that some employers find it more cost-effective to send their employees to Boston for certain surgeries or care.

The findings of these studies and others do not come as a surprise to me, nor to Maine employers and consumers. The majority of our members in Maine work for companies that are self-funded, which means an insurer like Anthem administers the plan, but the employer pays for health care costs directly; any increases health systems charge for medical expenses is a direct increase in the expenses they pay. Employers with “traditional” plans, where the insurer assumes the risks and the costs, see their premiums increase as costs go up.

Simply put, the prices health systems charge for services is the primary driver of health care spending. If the cost of services continues to rise unchecked, all Mainers will pay more for health care through higher premiums and higher out-of-pocket costs. If that sounds unsustainable, that’s because it is.

At Anthem, our role is to protect our customers from increased costs and to protect affordability for the businesses and people we serve. That’s the whole reason why we enter into contractual relationships with providers and health systems: to be stewards of our customers’ money.

Our work is as important now as ever. Through routine audits, we discovered MaineHealth has overcharged our members. In 2018, we discovered overbilling by Maine Medical Center in Portland for anesthesia and operating room services. As a result of an investigation, MaineHealth eventually acknowledged the overcharging and issued refunds amounting to nearly $20 million. If it were not for our internal audits – a system of checks and balances to protect our members – these overcharges may never have been discovered.

Unfortunately, we find ourselves in a similar situation, where through a routine audit, it was discovered that MaineHealth has once again overcharged Maine consumers and charged them for services they shouldn’t have, which we believe totals millions of dollars. Disputing such charges is at the heart of the current dispute with MaineHealth.

Anthem has been partners with MaineHealth for decades, and in order for all Mainers to have access to high-quality, outcomes-driven health care, we believe strongly that this partnership must continue. To help resolve these matters with MaineHealth, we have engaged an independent mediator.

As, respectively, the largest payer and provider in the state, Anthem and MaineHealth have a responsibility to address the challenges of rising health care costs on behalf of the people we mutually serve. We at Anthem Blue Cross and Blue Shield agree with the governor that it is in the best interests of consumers to come back to the negotiating table and hash out our differences. I am committed to doing so, as are the hundreds of Mainers I work with every day. We are hopeful MaineHealth will join us.

https://www.pressherald.com/2022/04/26/anthem-president-were-working-to-protect-health-care-affordability/

Letter to the editor: MaineHealth-Anthem conflict symbol of something bigger

The dispute between MaineHealth and Anthem is a perfect illustration of why for-profit health care is a bad idea.

Philip Moss
Cape Elizabeth

https://www.pressherald.com/2022/04/28/letter-to-the-editor-mainehealth-anthem-conflict-symbol-of-something-bigger/

Covid Drugs Save Lives, but Americans Can’t Get The Them

Almost two months after President Biden promised to make lifesaving drugs against Covid widely available to Americans, the medications remain hard to get for many, despite supplies, leaving large numbers of Americans to face increased risks of avoidable death and serious illness.

That’s largely because, once again, a dysfunctional health care system that costs more and often delivers less than that of any other developed country has hindered our pandemic response.

As was the case with vaccines, the United States quickly snapped up these therapeutics and accumulated vastly more supply than any other country. These drugs do not replace vaccines but provide crucial extra protections for vulnerable people who number in the millions and who face increased risks as the few remaining public health protections are rolled back.

Paxlovid, an antiviral treatment developed by Pfizer, an American pharmaceutical company, is highly effective for reducing hospitalizations and deaths in high-risk patients, as long as it is started early. This is especially important for elderly or immunocompromised people, since their immune systems are not as robust as others’ against viruses, even when vaccinated. In his State of the Union address, Biden announced a “test to treat” initiative to provide such pills on the spot in pharmacies when someone tests positive.

Reality is much less rosy.

The national map of participating pharmacies in test to treat shows large parts of the country with none. Even in areas where treatment is supposed to be available, it can be hard to get. A Kaiser Health News reporter spent three hours driving around Washington, D.C., before finding a pharmacy where testing was available and the drug was in stock — something we should not expect sick people to do. When trying to book appointments online in several states, the reporter was sometimes denied an in-person appointment after listing upper-respiratory symptoms and a positive coronavirus test, even though the point of the program is to treat people with respiratory illness so they don’t get sicker. Many places did not have any same-day appointments, a big obstacle for a drug that should be given as quickly as possible.

The greater difficulty is that the drug can be prescribed only by a medical doctor, advanced practice registered nurse or physician assistant, especially because it can interact harmfully with many other drugs. It cannot be prescribed by a pharmacist. Many pharmacies aren’t participating in the national program because they don’t have a clinic on site where a health practitioner can assess a person’s eligibility. Even if they have one, managing prescriptions for high-risk people is best done by a patient’s regular doctor, not in a one-off encounter at a pharmacy. Patients who successfully wangle an appointment are asked to bring a list of all their drugs and, I suppose, resolve all the complexities in one sitting.

As further congressional funding has not been approved, the funds used for reimbursement for coronavirus testing have begun to be depleted, so people without insurance or whose insurance doesn’t cover such clinics have to pay for the health appointment out of pocket.

So it’s not hard to predict that many people will be left behind.

What about those with proper health insurance and a primary care physician? Fine, as long as your doctor is aware of the drug and you can get an appointment quickly and then locate the drug.

Several physicians have told me they had to intervene on behalf of their elderly or high-risk relatives who tested positive, calling their health care providers directly to persuade them to prescribe the antiviral. These may be anecdotal, but even Dr. Anthony S. Fauci, the president’s chief medical adviser, noted last week that the drug was “being underutilized.”

If many doctors are unaware of these therapeutics or unsure how patients qualify for them, where’s the effective awareness and education campaign for health care providers?

In the United States, such doctor outreach is often, sadly, left to pharmaceutical companies, which spend tens of billions of dollars each year marketing their drugs to physicians. This has led to heavily promoted drugs getting prescribed even when cheaper, effective alternatives exist. However, Paxlovid received an emergency use authorization, which means that legally, Pfizer cannot directly market it yet, so physicians don’t get even this sort of outreach. This leaves individual doctors on their own for keeping up with new drugs and treatments, even in a pandemic and even when the drug is potentially lifesaving.

Also, it’s not that easy to get a same-day appointment with one’s regular physician, even for those who have great insurance. This makes catching the early treatment window harder. In most places, emergency rooms are always open, but besides being overloaded and understaffed, they are the last places where infected people should congregate or where the elderly or those at high risk should spend hours merely to get access to a crucial drug.

A similar situation is underway for Evusheld, a Covid drug approved in December for the millions of immunocompromised people, like transplant patients and those on medications that can suppress the immune system for conditions like rheumatoid arthritis. In trials, the drug reduced symptomatic infections by about 83 percent. This drug provides them with extra protection for six months as a prophylactic. It’s been approved for months, and Biden also mentioned treatments for the immunocompromised in his State of the Union address. The federal government bought 1,700,000 doses, to be distributed free.

So I guess this is where I should say, “Stop me if you heard this before.”

In March, The New York Times reported that a whopping 80 percent of the doses were sitting unused as the Omicron wave washed over the country. A CNN investigation found desperate patients unable to find the drug, doctors unaware that it even exists and some pharmacies with hundreds of unused doses while others had none. Hospitals like the Mayo Clinic told CNN that they had only a few thousand boxes for the more than 10,000 patients who could benefit from it, while boxes were delivered to medical spas offering Botox or eyelash extensions (and sitting unused). The Detroit Free Press found supplies of Paxlovid and Evusheld unused because physicians weren’t prescribing them. A Kaiser Health News investigation found that government maps of supplies were missing many locations that had doses. This happened even as desperate patients waited for lotteries to allocate some to them. Social media is also replete with stories of despondent patients unable to locate doses or managing to do so after much effort and paying extra when they ended up out of their insurance networks. Meanwhile, at least one infusion center had so many unused doses that it ran out of refrigerator space and declined new shipments.

What makes this all more troubling is that conditions like diabetes and uncontrolled high blood pressure increase the dangers of Covid and the United States has had a worse record on such health indicators than many other wealthy nations.

Not having a regular relationship with a medical provider — too common in the United States — leaves these high-risk people open to confusion and misinformation, especially in the current political environment. People without insurance lagged in being vaccinated at all and will face more obstacles in getting antivirals.

In Britain, which has a national health system, 58 percent of people have received a third vaccine dose. In the United States the number is a measly 30 percent. Well, I should say we think it is; without a national health system, the United States has difficulty keeping track of the numbers. The failure to reach more people with a third dose, shown by the data to greatly help with outcomes, cannot be blamed solely on anti-vaccination attitudes, as 66 percent of the U.S. population had received two doses.

In October 2019, a Johns Hopkins study found the United States more prepared than any other country for a pandemic. Obviously, that prediction did not age well. But taking a look at how the study got it wrong is instructive.

On many of the indicators the researchers examined, the United States ranked high, often in the top five, with one conspicuous exception: access to health care. On that measure, the researchers placed the United States 183rd out of 195 countries. In retrospect, maybe they should have made that the primary criterion.

What is the point of talking about health care access and outlining how it manifests itself in failure after failure, given that the Republican Party seems determined to block progress and even roll back what little improvement we have had with the Affordable Care Act, or Obamacare?

The most important reason is that to do otherwise would restrict the possibilities for change and our political imagination even further. Lowering the eligibility age for Medicare to 60 and then to 55 and expanding the Veterans Health Administration, the largest integrated health care system in the country, to include firefighters, social workers, teachers and others who serve their communities are among the options that should become part of the political conversation.

And any obstacles on the federal level should inspire states to overcome these problems themselves and even build their own systems.

New York City, for example, has created a hotline to provide Covid information, including how to get Paxlovid free, with home delivery, and how those without a doctor can reach one quickly through a telehealth appointment. In the earlier waves, the hotline also connected people with free hotel rooms if they needed to isolate away from their homes. It will also allow people to request delivery of basic supplies like masks and thermometers to their homes. And I’ve seen all this advertised a lot, including on local TV stations. We need more such efforts.

There’s more the federal government can do now, like start a robust physician and patient outreach program and work to clarify and balance the supply of therapeutics for Covid so that millions of immunocompromised people can better protect themselves and high-risk people who get infected can avoid severe disease.

However, states should be aware that this may not be coming and should begin their own programs and maybe even cooperate to build shared infrastructure. Under these political conditions, rescue may not be on its way for a long time, if ever. We can at least try to build better lifeboats, locally, wherever possible.

https://www.nytimes.com/2022/04/22/opinion/covid-pandemic-drugs-treatment.html 

Hit with $7,146 for two hospital bills, a family sought health care in Mexico 

by Paula Andalo - Kaiser Health News - April 27, 2022

The Fierro family of Yuma, Ariz., had a string of bad medical luck that started in December 2020.

That's when Jesús Fierro Sr. was admitted to the hospital with a serious case of COVID-19. He spent 18 days at Yuma Regional Medical Center, where he lost 60 pounds. He came home weak and dependent on an oxygen tank.

Then, in June 2021, his wife, Claudia Fierro, fainted while waiting for a table at the local Olive Garden restaurant. She felt dizzy one minute and was in an ambulance on her way to the same medical center the next. She was told her magnesium levels were low and was sent home within 24 hours.

The family has health insurance through Jesús Sr.'s job, but it didn't protect the Fierros from owing thousands of dollars. So when their son Jesús Fierro Jr. dislocated his shoulder, the Fierros — who hadn't yet paid the bills for their own care — opted out of U.S. health care and headed south to the U.S.-Mexico border.

And no other bills came for at least one member of the family.

The patients: Jesús Fierro Sr., 48; Claudia Fierro, 51; and Jesús Fierro Jr., 17. The family has Blue Cross and Blue Shield of Texas health insurance through Jesús Sr.'s employment with NOV, formerly National Oilwell Varco, an American multinational oil company based in Houston.

Medical services: For Jesús Sr., 18 days of inpatient care for a severe case of COVID-19. For Claudia, fewer than 24 hours of emergency care after fainting. For Jesús Jr., a walk-in appointment for a dislocated shoulder.

Total bills: Jesús Sr. was charged $3,894.86. The total bill was $107,905.80 for COVID-19 treatment. Claudia was charged $3,252.74, including $202.36 for treatment from an out-of-network physician. The total bill was $13,429.50 for less than one day of treatment. Jesús Jr. was charged $5 (70 pesos) for an outpatient visit that the family paid in cash.

Service providers: Yuma Regional Medical Center, a 406-bed nonprofit hospital in Yuma, Ariz. It's in the Fierros' insurance network. And a private doctor's office in Mexicali, Mexico, which is not.

What gives: The Fierros were trapped in a situation in which more and more Americans find themselves. They are what some experts term "functionally uninsured." They have insurance — in this case, through Jesús Sr.'s job, which pays $72,000 a year. But their health plan is expensive, and they don't have the liquid savings to pay their share of the bill. The Fierros' plan says their out-of-pocket maximum is $8,500 a year for the family. And in a country where even a short stay in an emergency room is billed at a staggering sum, that means minor encounters with the medical system can take virtually all the family's disposable savings, year after year. And that's why the Fierros opted out of U.S. health care for their son.

According to the terms of the insurance plan, which has a $2,000 family deductible and 20% coinsurance, Jesús Sr. owed $3,894.86 out of a total bill of nearly $110,000 for his COVID-19 care in late 2020.

The Fierros are paying off that bill — $140 a month — and still owe more than $2,500. In 2020, most insurers agreed to waive cost-sharing payments for COVID-19 treatment after the passage of federal coronavirus relief packages that provided emergency funding to hospitals. But waiving treatment costs was optional under the law. And although Blue Cross and Blue Shield of Texas has a posted policy saying it would waive cost-sharing through the end of 2020, the insurer didn't do that for Jesús Sr.'s bill. Carrie Kraft, a spokesperson for the insurer, wouldn't discuss why his bill was not waived.

(More than two years into the coronavirus pandemic and with vaccines now widely available to reduce the risk of hospitalization and death, most insurers again charge patients their cost-sharing portion.)

On Jan. 1, 2021, the Fierros' deductible and out-of-pocket maximum reset. So when Claudia fainted — a fairly common occurrence and rarely indicative of a serious problem — she was sent by ambulance to the emergency room, leaving the Fierros with another bill of more than $3,000. That kind of bill is a huge stress on many American families; fewer than half of U.S. adults have enough savings to cover a surprise $1,000 expense. In recent polling by the Kaiser Family Foundation, "unexpected medical bills" ranked second among family budget worries, behind gas prices and other transportation costs.

The new bill for the fainting spell destabilized the Fierros' household budget. "We thought about taking a second loan on our house," said Jesús Sr., a Los Angeles native. When he called the hospital to ask for financial assistance, he said, people he spoke with strongly discouraged him from applying. "They told me that I could apply but that it would only lower Claudia's bill by $100," he said.

So when Jesús Jr. dislocated his shoulder when boxing with his brother, the family headed south.

Jesús Sr. asked his son, "Can you bear the pain for an hour?" The teen replied, "Yes."

Father and son took the hourlong trip to Mexicali, Mexico, to Dr. Alfredo Acosta's office.

The Fierros don't consider themselves "health tourists." Jesús Sr. crosses the border into Mexicali every day for his work, and Mexicali is Claudia's hometown. They've been traveling to the neighborhood known as La Chinesca (Chinatown) for years to see Acosta, a general practitioner, who treats the asthma of their youngest son, Fernando, 15. Treatment for Jesús Jr.'s dislocated shoulder was the first time they had sought emergency care from the physician. The price was right, and the treatment effective.

A visit to a U.S. emergency room likely would have involved a facility fee, expensive X-rays and perhaps a specialist's evaluation — which would have generated thousands of dollars in bills. Acosta adjusted Jesús Jr.'s shoulder so that the bones aligned in the socket and prescribed him ibuprofen for soreness. The family paid cash on the spot.

Although the Centers for Disease Control and Prevention doesn't endorse traveling to another country for medical care, the Fierros are among millions of Americans each year who do. Many of them are fleeing expensive care in the U.S., even with health insurance.

Acosta, who is from the Mexican state of Sinaloa and is a graduate of the Autonomous University of Sinaloa, moved to Mexicali 20 years ago. He witnessed firsthand the growth of the medical tourism industry.

He sees about 14 patients a day (no appointment necessary), and 30% to 40% of them are from the United States. He charges $8 for typical visits.

In Mexicali, a mile from La Chinesca, where the family doctors have their modest offices, there are medical facilities that rival those in the United States. The facilities have international certification and are considered expensive, but they are still cheaper than hospitals in the United States.

Resolution: Both Blue Cross and Blue Shield of Texas and Yuma Regional Medical Center declined to discuss the Fierros' bills with KHN, even though Jesús Sr. and Claudia gave written permission for them to do so.

In a statement, Yuma Regional Medical Center spokesperson Machele Headington said, "Applying for financial support starts with an application — a service we extended, and still extend, to these patients."

In an email, Kraft, the Blue Cross and Blue Shield of Texas spokesperson, said: "We understand the frustration our members experience when they receive a bill containing COVID-19 charges that they do not understand, or feel may be inappropriate."

The Fierros are planning to apply to the hospital for financial support for their outstanding debts. But Claudia said never again: "I told Jesús, 'If I faint again, please drive me home,' " rather than call an ambulance.

"We pay $1,000 premium monthly for our employment-based insurance," added Jesús. "We should not have to live with this stress."

The takeaway: Be aware that your deductible "meter" starts over every year and that virtually any emergency care can generate a bill in the thousands of dollars and may leave you owing your deductible and most of your out-of-pocket maximum.

Also be aware that even if you seem not to qualify for financial assistance based on a hospital's policy, you can apply and explain your circumstances. Because of the high cost of care in the U.S., even many middle-income people qualify. And many hospitals give their finance departments leeway to adjust bills. Some patients discover that if they offer to pay cash on the spot, the bill can be reduced dramatically.

All nonprofit hospitals have a legal obligation to help patients: They pay no tax in exchange for providing "community benefit." Make a case for yourself, and ask for a supervisor if you get an initial no.

For elective procedures, patients can follow the Fierros' example, becoming savvy health care shoppers. Recently, Claudia needed an endoscopy to evaluate an ulcer. The family called different facilities and discovered a $500 difference in the cost of an endoscopy. They will soon drive to a medical center in Central Valley, California, two hours from home, for the procedure.

The Fierros didn't even consider going back to their local hospital. "I don't want to say, 'Hello' and receive a $3,000 bill," joked Jesús Sr. 

https://www.mainepublic.org/npr-news/2022-04-27/hit-with-7-146-for-two-hospital-bills-a-family-sought-health-care-in-mexico

Saturday, April 23, 2022

Health Care Reform Articles - April 18, 2022

Editor's Note -

This link will take you to a very good NPR story about  the history of health insurance in the US . It is well worth the hour it will take to listen to the whole thing. It puts our current struggle to fix the American health care system into perspective.

- SPC

$136 for a $2 bag of saline? Anthem, MaineHealth trade blame in billing disputes

Anthem accuses the hospital network of overbilling and hiding charges; MaineHealth says the insurer is arbitrarily withholding payments.

by Joe Lawlor - Portland Press Herald - April 17, 2022

An IV bag of saline costs Maine Medical Center $2, but the Portland hospital has charged patients covered by Anthem insurance a total of $136 per bag and also tried to hide the bill, according to Anthem.

Anthem, on the other hand, refuses to pay Maine Medical Center for multiple procedures performed on one patient in the same day, according to the hospital’s parent, MaineHealth. So when a heart patient recently needed two stents, Anthem would pay for only one, the hospital network alleges.

Anthem, the state’s largest insurer, and MaineHealth, the state’s biggest health care network, provided the Press Herald with those and other examples of billing issues they say have added up to millions of dollars in overcharges and underpayments.

The unusual public accusations and details open a rare window on the health care industry’s behind-the-scenes clashes over medical costs and insurance coverage. Medical billing is a notoriously confusing and complex system, with charges that can vary widely for the same procedures. And it’s a system that is opaque for most consumers.

The feud became public this month when MaineHealth announced that Maine Medical Center, the state’s largest hospital, would leave Anthem’s insurance network next January, a decision that would force thousands of patients to pay far higher costs for out-of-network care. MaineHealth said it announced the move because Anthem was shortchanging Maine Med $1 million per month in medication reimbursements while also accusing the insurance company of slow processing and routine denials of $70 million in payments across the health care network.

Anthem has faced similar allegations in other states. Two California hospitals threatened to leave the insurer last year over the same issues but ultimately settled, and Georgia fined Anthem $5 million in March for the way it was paying claims.

If the dispute here can’t be resolved, it could affect at least 300,000 Maine patients who have Anthem insurance coverage — about 54 percent of the state’s market, according to the Maine Bureau of Insurance. Maine Med’s break with Anthem also could disrupt the state’s entire health insurance system by forcing large-scale shifts to other carriers. The potential impacts prompted Gov. Janet Mills to urge both sides to settle the dispute.

But they appear to be far apart.

Anthem officials said a major reason an agreement is so far out of reach is that MaineHealth is overcharging for patient care. They provided the Press Herald with partially redacted medical claims to support the accusation, including two claims that show Maine Med charged $136 for $2 worth of saline – 50 milliliters of saltwater routinely used in IV bags as a vehicle to deliver medicine to patients in hospitals. All patient information was redacted from the claims.

Overcharging doesn’t just drive up the insurer’s costs. It also means patients can end up paying higher out-of-pocket costs, according to Anthem.

“Charges for saline – which they shouldn’t be charging for in the first place – and overcharges for other medications impact consumers in the form of higher cost shares through deductibles and co-insurance,” Denise McDonough, president of Anthem Blue Cross and Blue Shield in Maine, said in a statement. “Businesses in Maine will pay more through higher premiums or, for our self-funded customers, higher direct costs. At Anthem, our role is to advocate for consumers by protecting affordability. We are stewards of our customers’ money, which is why we are standing up to MaineHealth and asking them to right this wrong.”

MaineHealth officials did not directly respond to the accusations about saline overcharging but said Anthem is cherry-picking data and trying to create a distraction from the central issues of the insurer failing to pay MaineHealth what it’s owed for services.

And MaineHealth is leveling its own accusations.

By using loopholes in the contract, Anthem is at times refusing to pay for legitimate medical services, according to MaineHealth. Sometimes, it said, Anthem will refuse to pay for two procedures that occur on the same day. So when a heart patient recently needed surgeries for two stents, Anthem would pay for only one.

The unreimbursed costs are part of the broader dispute over millions of dollars that MaineHealth claims it is owed by Anthem.

“These changes weren’t negotiated in a contract,” said John Porter, MaineHealth spokesman. “They’re finding different ways to come up with new policies which change our model for getting paid. We can’t do business like this.”

Anthem officials said denying claims that appear to be duplications of services is an industry standard as a safeguard against double charging by a health care provider. If separate medical services are performed, the claim will be paid, they said.

“We have a responsibility to our members and customers to ensure the health care services they receive are coded, billed, and reimbursed appropriately and in accordance with our policies aligned with industry standards,” McDonough said.

Kate Ende, policy director for the Maine nonprofit Consumers for Affordable Health Care, said the dispute illustrates how the health care system’s complex way of financing and the push-pull of negotiations between insurance companies and health care providers often doesn’t end in a way that’s best for consumers. In the case of the Anthem and MaineHealth dispute, it could end with patients shut out of care at a major hospital and disruption in the insurance market.

“The system is overly complex and you have each party with different, competing interests,” Ende said. Health care networks and insurance companies “through a variety of mechanisms and levers are trying to reduce their costs or increase profitability.”

“The consumer is often the one left holding the bag,” Ende said.

A key factor in the dispute is MaineHealth’s accusation that Anthem is improperly reducing reimbursements for prescription drugs.

The hospital network says the underpayments effectively erase the benefits Maine Medical Center should be getting from a federal discount program known as 340B. Participating hospitals get discounted drugs in return for the care they provide to uninsured and low-income patients.

The 340B discount amounts to about $1 million per month in cost savings to Maine Med. But MaineHealth says Anthem has reduced reimbursements to effectively eliminate the hospital’s savings. Porter said Anthem is demanding MaineHealth charge Anthem only for drugs “based on acquisition costs.”

Anthem spokeswoman Stephanie DuBois has said the dispute of prescription drug reimbursements is not about the 340B discount but “goes back to the fact that MaineHealth unilaterally raised charges, which is costing our members and all of Maine Medical Center consumers more money. We can’t allow that to happen,” she said.

Anthem, meanwhile, says the hospital’s saline bills are an example of Maine Med overcharging.

Anthem officials said they believe the practice is more widespread but that the charges are hidden, such as being listed as a pharmacy charge that would show up only on an itemized bill.

During an audit of 96 claims, Anthem found $258,000 in saline charges hidden in bills, officials said. They provided the Press Herald with two bills that show the $136 saline charge. Anthem officials said they don’t know the scope of the problem, and could provide no evidence that it is widespread, because MaineHealth will not provide bill details that would reveal actual charges for saline.

“We have asked MaineHealth for data so we know the full scope of the issue, and they have refused,” Anthem’s McDonough said. “This is why both Anthem and MaineHealth engaged an independent mediator to help resolve this matter. We remain committed to this process in an effort to resolve this matter and hope MaineHealth will rejoin us.”

Much of the $136 Maine Med has billed for saline is broken out as a $125 restocking fee, according to Anthem. The bills provided to the Press Herald did not include a detailed breakdown of the $136 charge.

“The fee is a money grab to inflate revenues, pure and simple,” McDonough said. “Anthem members should not be charged for saline in the first place, let alone have to pay an exorbitant fee on something that should only cost approximately $2 a bag.”

Another example of overcharging, according to Anthem, is the hospital’s inflated charge for Alloderm, which is a tissue used in breast reconstruction for cancer patients. Anthem says the Alloderm should cost $20,000 but that Maine Medical Center is charging $50,000. It provided a bill showing a $50,000 charge.

Porter, while not specifically responding to the overcharging accusation, said Anthem is trying to divert attention from the insurer’s “routine denials for coverage of needed care” and refusal to pay for services. And he cited Anthem’s contract disputes with providers in other states.

“It is therefore disappointing, but not surprising given that it has resorted to this tactic in other states where its practices have been at issue, that Anthem is taking hospital pricing data out of context and trying to distract attention from these well documented issues,” Porter said. “We would urge Anthem to focus its attention on the needs of patients, who understandably have a lot of questions about how Maine Medical Center’s departure from its network in 2023 will affect them.”

Indianapolis-based Anthem operates in 14 states and has been involved in similar disputes with other health care networks, some of which have also publicly criticized its practices and threatened to leave the Anthem network.

Two California hospital operators announced last year they would terminate their contracts and leave the Anthem network. The CEO of one hospital, Shasta Regional Medical Center in Redding, accused Anthem of “repeated breaches of our contract,” while Anthem accused the hospital of trying to back out of an agreement to get higher reimbursement rates. Both California hospital operators later reached new contracts with Anthem and did not leave the network.

Last month, Anthem was fined $5 million by the Georgia Bureau of Insurance for problems that included improper claims settlement practices and slow reimbursements.

The Maine Bureau of Insurance has launched an investigation of Anthem after getting numerous complaints from health care providers about underpaying claims, a high proportion of denied claims and slow reimbursements. That investigation is expected to take months.

Ende, of Consumers for Affordable Health Care, said the bottom line is that there is weak regulation of the cost of health care and little protection for consumers.

“There’s not a lot of oversight in how hospitals set prices,” Ende said.

“There’s nothing to ensure the consumers’ interests are really being represented in all of this,” Ende said of the dispute between MaineHealth and Anthem. “There are these different, competing interests, but nobody is there fully on behalf of the consumer.”

 

 

Maine community health centers devastated by lack of funding

Anthem president: We’re working to protect health care affordability

The insurer is committed to coming back to the negotiating table, and it hopes MaineHealth will join them, Denise McDonough says.

 by Denise McDonough - Portland Press Herald - April 26, 2022
 
All of us at Anthem Blue Cross and Blue Shield in Maine are deeply committed to providing our 300,000 members access to high quality, outcomes-driven health care. We believe MaineHealth shares these goals. Where our two perspectives diverge, however, is that our work centers on ensuring that care is affordable.

The reality is, health care costs in Maine are high – some of the highest in the country – and if we are not vigilant, they’ll continue to climb higher. An objective 2019 study by the University of Pennsylvania ranked Maine as having the fourth highest health care cost burden for working families in America, and a 2020 study by the Rand Corp. showed prices paid to hospitals in Maine by private insurers are 252 percent of what Medicare would have paid for the same services at the same facilities.

The result? Maine can be such an expensive state for health care that some employers find it more cost-effective to send their employees to Boston for certain surgeries or care.

The findings of these studies and others do not come as a surprise to me, nor to Maine employers and consumers. The majority of our members in Maine work for companies that are self-funded, which means an insurer like Anthem administers the plan, but the employer pays for health care costs directly; any increases health systems charge for medical expenses is a direct increase in the expenses they pay. Employers with “traditional” plans, where the insurer assumes the risks and the costs, see their premiums increase as costs go up.

Simply put, the prices health systems charge for services is the primary driver of health care spending. If the cost of services continues to rise unchecked, all Mainers will pay more for health care through higher premiums and higher out-of-pocket costs. If that sounds unsustainable, that’s because it is.

At Anthem, our role is to protect our customers from increased costs and to protect affordability for the businesses and people we serve. That’s the whole reason why we enter into contractual relationships with providers and health systems: to be stewards of our customers’ money.

Advertisement

Our work is as important now as ever. Through routine audits, we discovered MaineHealth has overcharged our members. In 2018, we discovered overbilling by Maine Medical Center in Portland for anesthesia and operating room services. As a result of an investigation, MaineHealth eventually acknowledged the overcharging and issued refunds amounting to nearly $20 million. If it were not for our internal audits – a system of checks and balances to protect our members – these overcharges may never have been discovered.

Unfortunately, we find ourselves in a similar situation, where through a routine audit, it was discovered that MaineHealth has once again overcharged Maine consumers and charged them for services they shouldn’t have, which we believe totals millions of dollars. Disputing such charges is at the heart of the current dispute with MaineHealth.

Anthem has been partners with MaineHealth for decades, and in order for all Mainers to have access to high-quality, outcomes-driven health care, we believe strongly that this partnership must continue. To help resolve these matters with MaineHealth, we have engaged an independent mediator.

As, respectively, the largest payer and provider in the state, Anthem and MaineHealth have a responsibility to address the challenges of rising health care costs on behalf of the people we mutually serve. We at Anthem Blue Cross and Blue Shield agree with the governor that it is in the best interests of consumers to come back to the negotiating table and hash out our differences. I am committed to doing so, as are the hundreds of Mainers I work with every day. We are hopeful MaineHealth will join us.

https://www.pressherald.com/2022/04/26/anthem-president-were-working-to-protect-health-care-affordability/ 

 

Thursday, April 14, 2022

Health Care Reform Articles - April 14, 2022

 The US Healthcare System in Comparative View
 
                                                                    Testimony of Professor Jeffrey D. Sachs
                                                                    University Professor, Columbia University
 
                                                                    House Oversight and Reform Committee
                                                 Hearing on “Examining Pathways to Universal Health Coverage”
                                                                                       March 29, 2022
 
The US healthcare system is dysfunctional compared with our peer nations (other high-income democracies). The US system is far more expensive (per person and as a share of GDP) than peer countries. The US health outcomes are far worse. Life expectancy in the US lags several years behind our peer nations.  In the US, life expectancy stagnated between 2012 and 2019 at 78.8 years, whereas in the European Union, life expectancy rose from 80.2 years in 2012 to 81.3 years in 2019. (1)
 
The Commonwealth Fund has recently offered a detailed comparison of the healthcare systems of the US and 10 peer (comparison) countries: Australia, Canada, France, Germany, Netherlands, New Zealand, Norway, Sweden, Switzerland, and the United Kingdom. (2)  I will also use these ten countries as the sample of peer countries in my testimony.
 
Some Congressmen claim that there are no true peer countries because the US is larger than the other countries and more diverse. For that reason, it is useful to compare the US healthcare system not only with individual countries, but with the European Union (EU) as a whole.(3) Both the US and EU are diverse, with richer and poorer regions.  Yet the EU nations share basic healthcare principles that are far more effective than those of the US.  As a result, the EU healthcare system overall is fairer, less expensive, and with comparable or superior outcomes to the US.      
 
There are three basic questions about the design of a healthcare system:
 
(1) Who is covered?
(2) Who pays?
(3) Who sets the prices?
 
The basic difference of the US and the peer countries (and EU as a whole) is summarized in Table 1.  These are statements of general principle, with variation among the individual countries. 
 
 
 
Table 1.  Basic Differences in Healthcare Systems between the US and Peer Countries

 Who is Covered?Who Pays?Who Sets Healthcare Prices?Outcomes
USPartial CoverageHalf public payer, half private payerMostly unregulatedHigh cost, many people uninsured or underinsured, health debts and bankruptcy, falling life expectancy
Peer CountriesUniversal CoverageMostly public payer, through a combination of government transfers and mandatory social insuranceRegulated by governmentModerate cost, universal coverage, little or no health debt, rising life expectancy
 
The peer systems can be described as Universal, Public-Payer, and Price-Regulated.  They are not systems of socialized medicine, with the exception of the UK National Health Service, which is state-run.  In the other countries, healthcare providers are (mostly) non-governmental health professionals such as private doctors, private group practices, and not-for-profit hospitals. The difference between these peer countries and the US is that the peer healthcare workers are remunerated mostly by public funds, whereas in the US, public and private funding are each around half of the total. 
 
Public funding in Europe takes two main forms. In the Nordic countries, the UK, and some others, funding comes out of general government revenues.  In France, Germany, the Netherlands, and Switzerland, funding comes from compulsory social contributions, often paid to private, regulated insurers.  In all of the peer countries, private health providers face government regulated prices aimed at keeping drug prices and other healthcare costs under control.  The specific coverage of these regulated prices varies across countries.   
 
The most important comparisons are shown in Figures 1 and 2 and Table 2, taken from the most recent Commonwealth Fund comparison report and Our World in Data.  The US spends by far the most on healthcare of any of the 11 countries (Figure 1).  As of 2019, health spending in the US was nearly 18% of GDP, compared with 10-12% of GDP in the peer countries.  In dollars per capita, the US spending in 2019 was around $10,000 per capita, compared with roughly $4,000 - $7,000 in the peer countries.  In 2020, the first year of the pandemic, US national health expenditures rose to nearly 20% of GDP, more than $12,000 per capita.

 
Figure 1. Health Care Spending as a Percentage of GDP, 1980–2019. Notes: Current expenditures on health. Based on System of Health Accounts methodology, with some differences between country methodologies. GDP refers to gross domestic product.
* 2019 data are provisional or estimated for Australia, Canada, and New Zealand.
Data: OECD Health Data, July 2021.
Source: Eric C. Schneider et al, Commonwealth Fund, “Mirror, Mirror 2021, Reflecting Poorly: Healthcare in the United States Compared to Other High-Income Countries,” August 2021.
 
Despite these far higher outlays, the US health outcomes are generally comparable or worse than in the peer countries.  Life expectancy in the US was 78.9 years in the 2019, while in the peer countries, it was in most cases between 81 and 84 years (Figure 2).  The Commonwealth Fund assesses the US to rank last (in 11th place of the 11 countries) in overall health system performance, with a last place in four of the five categories: access to care, administrative efficiency, equity, and healthcare outcomes (Table 2).    
 

Figure 2. Life expectancy, 1990-2019. Source: Riley (2005), Clio Infra (2015), and UN Population Division (2019). Max Roser, Esteban Ortiz-Ospina and Hannah Ritchie (2013) - "Life Expectancy". Published online at OurWorldInData.org. Retrieved from: 'https://ourworldindata.org/life-expectancy'
 

Table 2. Health Care System Performance Rankings. Data: Commonwealth Fund analysis. Source: Eric C. Schneider et al, Commonwealth Fund, “Mirror, Mirror 2021, Reflecting Poorly: Healthcare in the United States Compared to Other High-Income Countries,” August 2021.
 
Why are healthcare costs sky-high in the US? Voluminous evidence shows that this is due mainly to very high costs of procedures, drugs, and hospital days in the US; in short, to the unregulated pricing of health services. (4) US healthcare providers have enormous market power in their respective catchment areas, with very few providers.(5) Pharmaceutical companies have market power due to patent protection. As a result, healthcare providers and pharmaceutical companies are able to set prices far above marginal production costs. 
 
The drug companies are notorious for price gouging. An infamous recent example was Gilead’s pricing of Sofosbuvir, a drug that the company purchased from the inventor and then marketed at roughly 1000X times the marginal cost, thereby prolonging the US epidemic of Hepatitis C.  The company got rich, while US military veterans suffering from Hepatitis C got liver failure.  Such price gouging is defended in the name of “innovation,” but this is overly simplistic.  Sofosbuvir was developed by academic researchers, and then purchased by Gilead. 
 
Consider also Moderna’s lifesaving Covid-19 mRNA vaccine.  The NIH funded the basic science of mRNA vaccines for more than a decade, much of which was in partnership with Moderna. Moderna (and BioNTech-Pfizer) walked away with the profits of the mRNA vaccines, while the US government has bought the vaccines at commercial prices.    
 
The high prices of healthcare and pharmaceuticals translates into soaring profits and wealth of the healthcare industry.  Figure 3 is from a Wall Street Journal report on CEO compensation of large pharmaceutical companies.  Note that compensation runs in the tens of millions of dollars, simply staggering sums.  Figure 4 reports the salaries of hospital administrators of major not-for-profit hospitals. The salaries are astounding: several million dollars per year.
 

Figure 3. Highest-Paid Pharmaceutical CEOs. Source: Wall Street Journal, 2019. Note: Industry groups defined by Standard & Poor's. Shareholder return reflects 1-year total shareholder return through the month-end closest to each company's fiscal-year end. 
Data from: MyLogIQ LLC (pay); Institutional Shareholder Services (performance). [Accessed March 29, 2022: https://graphics.wsj.com/table/CEOPAY_slice_Pharma_0606
Figure 4. Top 10 Non-Profit Hospitals (2016-2017). Andrzejewski, Adam et al. “Top 82 US Non-Profit Hospitals: Quantifying Government Payments and Financial Assets.” Open The Books Oversight Report. June 2019. https://www.openthebooks.com/top-82-us-non-profit-hospitals-quantifying-government-payments-and-financial-assets--open-the-books-oversight-report/
 
Figure 5 shows in simple terms that the high-profits also show up in high stock-market returns. 
The S&P 500 health sector enjoyed annualized returns of 13% over the past 10 years, the third highest sector, lagging only behind IT and discretionary consumer products. 

Figure 5. Annualized Equity Returns by Sector (S&P 500). Source: S&P Dow Jones Indices. “S&P Sectors: US Equity.” Last updated February 28, 2022. [Accessed 20 March 2022: https://www.spglobal.com/spdji/en/index-family/equity/us-equity/sp-sectors/#overview]
 
Another source of high healthcare prices in the US are extremely high administrative costs.  As shown in Figure 6, administrative costs among private health insurers averages around 13% of total outlays, compared with around 3% for Medicare.  According to the OECD estimates in Figure 7, the US spends around 1.4 percent of GDP, roughly $300 billion a year on administrative costs, while our peer countries spend less than half of that share of GDP.
 

Figure 6. Uses of Premium Revenues in Fully Insured Markets, 2010 to 2012. Data from: Congressional Budget Office, using 2010 filings of the Supplemental Health Care Exhibit (National Association of Insurance Commissioners) and 2011 and 2012 filings of the Medical Loss Ratio Annual Reporting Form (Centers for Medicare & Medicaid Services). Source: Burns A, Ellis P, et al. “Private Health Insurance Premiums and Federal Policy,” Congress of the United States Congressional Budget Office Report, February 2016. www.cbo.gov/publication/51130
 

Figure 7. Governance and Administrative Costs as Percent of GDP. Source: OECD. https://data.oecd.org/health.htm
 
Shifting to a Universal, Public-Payer, and Price-Regulated system, as in our peer countries, would save a fortune for Americans.  Congressional opponents of public-payer system claim that such a move would be “unaffordable,” and often cite a 2018 study by Charles Blahous for the the libertarian-leaning Mercatus Center at George Mason University to that effect.(6) The Mercatus Foundation projected that a move to Medicare-for-All (M4A) would add an extra $32.6 trillion over 10 years (2022-2031) to the federal budget compared with the current baseline.  Yet the Mercatus study also estimated that non-federal outlays, mainly private outlays, would decline by $34.7 trillion over 10-years, for a net saving in overall health outlays equal to $2.1 trillion. This is summarized in Table 3 (data are in $ trillions).  In other words, households would save more by eliminating out-of-pocket payments and private health insurance premia than the government would raise in revenues to fund the public system. The public system would be cheaper for the nation, not more expensive.
 
Table 3. Net Cost Savings Of $2 Trillion in Mercatus Foundation Study


There are two more key facts to drive home this crucial point.  First, the increased government revenues would presumably be raised through progressive taxation, i.e., from higher-income taxpayers. The working-class households would therefore save twice, first in the reduction of overall health outlays, and second in the shift of financing towards higher-income households. 
 
Second, and at least as important, the overall cost saving should be much more than $2 trillion over ten years (though $2 trillion in saving over ten years is nothing to ignore).  The shift to M4A should include price regulation, as in every peer country.  The US now spends around 20% of GDP on health outlays, while our peer countries spend 10-12% of GDP because of lower unit costs.  The US healthcare costs under M4A might not fall all the way from 20% of GDP to 12% of GDP, but it is reasonable to think that the US could get health costs down to 15% of GDP, higher than in the peer countries, but far lower than today.  The savings would be then be around 5% of GDP, more than $1.1 trillion at the projected 2022 GDP of $23.7 trillion.
 
These are simply illustrative numbers. The actual saving would be determined by the detailed operation of the new system. The most important determinant of saving would be the pricing regulations introduced into M4A.    
 
Note that the single-state experiments in public financing, such as in Vermont, tell us very little about what would happen in a federal M4A system.  A state like Vermont is a “price taker” of the exorbitant US healthcare costs.  Vermont by itself can’t lower these costs through regulation, because healthcare providers and pharmaceutical companies would shift operations out of Vermont. Yet in a federal system, the health providers and drug companies could not shift operations outside of the US, since those overseas markets are already tightly regulated. 
 
It behooves us to ask why the US sticks with such a miserably broken and unfair system, one that is literally killing and bankrupting Americans.  The answer, alas, is the political power of the healthcare lobby.  As shown in Figure 8, using data from OpenSecrets.Org, the healthcare sector is the number 1 economic sector in lobbying outlays, having spent an extraordinary $10 billion on lobbying outlays during the period 1998-2021. The industry is also an extraordinary campaign funder.  In the 2019-2020 federal election cycle, health-sector PACs gave $49.2 million in campaign spending, divided roughly equally between Democrats and Republicans.(7)    
 
       
Figure 8. Lobbying by Industry ($billion), 1998-2021. Based on data released by the Federal Election Commission on March 22, 2021. Source: OpenSecrets.org [Accessed March 29, 2022: https://www.opensecrets.org/political-action-committees-pacs/industry-detail/H/2020]
 
 
(2) Commonwealth Fund, “Mirror, Mirror 2021, Reflecting Poorly: Healthcare in the United States Compared to Other High-Income Countries,” August 2021
(3) The US and the EU are of roughly comparable size.  The US has a population of 332 million; the EU, 447 million.  The US GDP in 2021 was $23 trillion; in the EU, $17 trillion. 
(4) See Barber SL, Lorenzoni L, and Ong P. “Price setting and price regulation in health care: lessons for advancing Universal Health Coverage,” World Health Organization and the Organisation for Economic Co-operation and Development, 2019.
(5) Lin, L and Mrkaic M. “U.S. Healthcare: A Story of Rising Market Power, Barriers to Entry, and Supply Constraints,” International Monetary Fund, 2021, 55 p. https://doi.org/10.5089/9781513585451.001
(6) Blahous, Charles, “The Costs of a National Single Health-Payer System,” Mercatus Working Paper, July 2018
(7) See https://www.opensecrets.org/political-action-committees-pacs/industry-detail/H/2020
 
 

Health care providers say Anthem billing problems are widespread

Maine is investigating the health insurer following complaints from medical associations about underpayment, payment delays and denied claims. 

by Peter McGuire - Portland Press Herald - April 9, 2022

Underpayments, unpaid claims and other billing complications are a chronic problem for independent health care providers using the Anthem insurance network, Maine doctors and professional associations say.

The medical providers echo some of the frustrations expressed by MaineHealth, the state’s largest hospital network, which stunned many this week when it announced that its flagship hospital, Maine Medical Center in Portland, would leave the Anthem network in January.

Problems faced by individual providers stretch back years but have multiplied since last summer, said Dr. Jeffrey Barkin, a psychiatrist and president of the Maine Medical Association.

Common issues include underpaying claims and a high proportion of denied claims, Barkin said. Recently, providers ran into problems because Anthem could not recognize their national identification numbers. When people try to fix the problems, Anthem’s customer service is difficult to reach or unavailable, the providers said.

The problem has led some clinicians to stop accepting Anthem insurance and the Maine Bureau of Insurance is investigating the corporation’s conduct in the state.

“The Maine Medical Association would like to see a harmonious relationship between providers and payers, but this sort of behavior directed toward hospitals, toward doctors, has absolutely no place in the health care ecosystem,” Barkin said.

In a statement on Friday, Anthem said it strives to pay claims as efficiently and quickly as possible in accordance with contracts it has with providers. Over the last year, the insurer processed 92 percent of claims within 14 days and 98 percent of claims within 30 days, said Stephanie DuBois, director of public relations for Anthem Blue Cross and Blue Shield in Maine.

Anthem set up a dedicated Maine provider assistance team to deal with the issues, DuBois added. The company did not answer directly when asked if there were widespread billing problems in Maine and why the company is unable to pay Maine providers on time.

“We’re proud of our progress, but these are complex issues that take time to address properly and we are committed to resolving them,” DuBois said. “We have communicated our progress to providers across Maine, and we will continue that direct dialogue as we continue to resolve these challenges.”

Maine Medical Center, the state’s largest hospital, will leave the Anthem insurance network in January because of its payment practices, according to Wednesday’s announcement by MaineHealth, the hospital’s parent organization. The breakup would mean patients with Anthem insurance would have to pay dramatically higher out-of-pocket costs for care at Maine Med, which would become an out-of-network provider.

In its announcement, MaineHealth said Anthem has underpaid the Portland hospital’s claims by $13 million and owes $70 million to the entire hospital network, which includes eight hospitals in Maine and one in New Hampshire. Anthem responded by accusing Maine Medical Center of overbilling for anesthesia and operating room services.

BILLING PROBLEMS WIDESPREAD

These are familiar and frustrating issues for many small practices around the state. Anthem’s billing problems have affected therapists, chiropractors, opticians, ophthalmologists and others, according to professional associations.

Lev Myerowitz, a chiropractor in Cape Elizabeth, said Anthem owes him hundreds of thousands of dollars, including from COVID-19 tests provided in 2020.

“First it was miscoding, then a software billing issue. I think they have run out of excuses. It is pretty obvious this is a clear, companywide approach,” Myerowitz said.

“I am not the only office,” he added. “This is across the state. Small businesses have absolutely zero ability to negotiate with large insurance. We have to choose to be in-network and accept the terms provided or not be in-network. To leave Anthem as a provider would be the same as not taking insurance completely.”

Last month, groups that included the Maine chapter of the National Association of Social Workers convened a meeting between about 100 providers and Anthem executives to address the problem, said Chris McLaughlin, the association’s executive director.

“To their credit, Anthem has dedicated some staff resources specifically to Maine to help sort through challenges. For some people it felt too little, too late. Some folks have made the decision to leave the Anthem network,” McLaughlin said.

LEAVING NETWORK IS RISKY

Leaving the network can be risky for providers and patients. The Indianapolis corporation covers 54 percent of insured Mainers and is one of the biggest health insurance companies in the U.S. If doctors, therapists and others stop taking the insurance, they could lose clients or force them to pay higher out-of-pocket costs.

“We don’t know the scale of the exodus,” McLaughlin said. “We heard from a lot of social work professionals that they feel compelled to suck this up and deal with it on behalf of their clients so they don’t lose services.”

Professional associations banded together last year to pressure the Bureau of Insurance to open an investigation of Anthem’s operations called a market conduct examination, said Bob Reed, executive director of the Maine Chiropractic Association.

The Bureau of Insurance did not answer questions Friday about its Anthem probe and the involvement of professional associations in pushing for the investigation.

“The bureau is conducting a market conduct examination of Anthem, which will include a review of provider payment issues. The exam is expected to continue for several months. At this time, Anthem has worked through most of its backlog of claims,” bureau spokeswoman Judith Watters said this week.

Reed said all insurers have billing problems, but the issue seems far more widespread in Anthem’s case. It also was an issue that appears to have  largely simmered under the surface before MaineHealth and Maine Medical Center brought attention to it.

“I think Maine Medical Center going public really opened up a lot of people’s minds about what we thought was a smaller issue,” Reed said. “Every doctor is going to be quiet. They think ‘it must just be me.’ Situations like this make them realize it is not the individual doctor.”

https://www.pressherald.com/2022/04/08/health-care-providers-say-anthem-billing-problems-are-widespread/ 

Is a Misguided Hospital Building Boom Coming?

A $2 billion expansion of Mass General Brigham in Boston could open the floodgates.

Stories about therapeutic triumphs performed by the nation’s academic medical centers (AMCs) are a media staple: CAR-T therapy mobilizes the body’s immune system to fight cancer! Patients are rising from their deathbeds after double lung-heart transplants! Academic researchers played the crucial role in developing the COVID-19 mRNA vaccine! 

And, if you’re like me, you have friends who, after receiving a dire diagnosis from their regular physician, hightailed it to a local or national AMC for a second opinion. They probably received their treatment there when the original diagnosis proved positive.

It’s called prestige medicine. Who wouldn’t want to go to Mayo, the Cleveland Clinic, or their local equivalent if you have a serious heart condition; or Memorial Sloan Kettering, MD Anderson, or the local academic cancer center if you develop a life-threatening tumor?

But is care there better? Not necessarily. As patient safety advocates like the Leapfrog Group have repeatedly shown, safety grades for leading academic hospitals can range anywhere from A to D, with some of the best known (like Northwestern and the University of Illinois in my home city of Chicago, for instance) barely earning passing marks.

As for outcomes, one recent study suggested that AMCs achieve better results than community hospitals when measured by death within the first 30 days after treatment. Yet the same study showed that they didn’t outperform when it came to routine surgical procedures. A recent health care consulting firm study was less sanguine, finding that AMCs actually trail their community-based rivals on key outcome measures.

One thing is for certain: AMCs cost more—a lot more if you are commercially insured. That has led many employers to adopt high-deductible plans, forcing patients to pick up the first $1,000 or more of the bill. Many insurers have begun excluding pricey academic centers from their networks, and many patients seeking out prestige medicine wind up paying higher out-of-pocket costs than if they went to their local community hospital.

But cost concerns have not stopped the nation’s 140-plus AMCs and their proliferating outpatient facilities from gaining substantial market share in recent years. In some markets, like Pittsburgh and Boston, they’ve become so dominant that no insurer can afford to exclude the system from its network, which gives AMCs extraordinary power to demand higher prices. And they do.

Recent developments are working to make this imbalance even worse in ways that will aggravate health care inflation and accelerate the rapid decline of community-based health care in rural and low-income areas across America, making the inequities of the current system even worse than they already are.

Consider what is happening in Boston right now. Mass General Brigham (MGB), a recent combination of two of the nation’s elite medical institutions, both affiliated with Harvard Medical School, last year announced a $2.3 billion expansion plan that would both modernize its two flagship hospitals and grow them by more than 100 beds. The original plan also called for building three outpatient surgical facilities in wealthy suburbs. The expansion plan has drawn widespread opposition from local community hospitals, insurers, patient advocacy groups, the state attorney general and the Massachusetts Health Policy Commission, whose mission includes controlling costs.

Last week, MGB withdrew the suburban portion of its expansion plan in the face of that opposition. But the state is leaning toward approving the main hospitals’ $2 billion reconstruction plan. A win for MGB, which could come within days, will not only accelerate the restructuring of that city’s hospital sector but could also open the floodgates to similar projects in other markets and deal a severe setback to efforts to rein in total U.S. health care spending, which already consumes 20 percent of GDP, the highest in the world by a long shot.

The restructuring of the nation’s hospital sector began well before COVID, the result of hospital utilization trends that show every sign of resuming after the pandemic has wound down. Numerous large hospital construction projects have been announced by major academic medical centers in recent months. 

The University of Chicago Medical Center recently announced plans to build a new $633 million cancer hospital, part of a $1 billion project that will grow its total capacity by 24 percent, to 597 beds. Several multi-billion-dollar expansion projects are under way at the University of California medical centers in San Diego and Irvine. Penn Medicine in Philadelphia just opened its $1.6 billion expansion project. There are also major projects on the drawing board at several big nonprofit systems that are dominant in their markets and serve as teaching hospitals for local medical schools.

All this construction will be taking place amid stagnant hospital admissions. On a per capita basis, the number of patients entering hospitals has been on the decline for decades, according to data from the American Hospital Association. Advancing technology, the rise of outpatient surgical centers, and the growing hospital-at-home movement have combined to reduce hospital admissions and in-patient lengths of stay, and with that, a concomitant reduction in the number of staffed beds inside hospitals.

The losers have been community-based hospitals in cities and regions with stagnant or declining populations and rural hospitals. The winners have been large systems and AMCs, whose nonprofit status, stable balance sheets, and superior reputations enable them to capture patients previously served by neighboring, community hospitals. The Massachusetts commission study estimated that MGB’s $2 billion expansion would not only lead to sharply higher prices for commercially insured patients but also shift $261 million a year in existing spending to MGB from struggling community hospitals.

“These providers often operate on thin margins, so even a small shift could remove a key revenue stream that enables them to serve patients who are insured by MassHealth (the state’s Medicaid program) or Medicare or patients who are uninsured,” wrote Tim Murray, the president of the Worcester Chamber of Commerce, and Amy Rosenthal, executive director of Health Care For All, a consumer advocacy group, in CommonWealth magazine. “The financial instability could ultimately force them to close or scale back critical medical, behavioral health, and other services.”

Massachusetts is one of only five states that have adopted a system that sets annual benchmarks for overall spending on health care. In 2019, the year covered in the state’s most recent annual report, spending rose by 4.3 percent, well above the 3.1 percent benchmark.

The Health Policy Commission blamed Mass General Brigham, the most expensive system in the state, for much of the excess spending. This past January, the state ordered MGB to develop a performance improvement plan to lower its overall costs, the first time in its history the commission has issued such an order.

“Mass General Brigham has a spending problem,” says HPC chairman Stewart Altman, a professor of health policy at Brandeis University. “Continuing in this manner is likely to impact the state’s ability to meet its spending benchmark and could do serious harm to the structure of the state’s delivery system.”

MGB, for its part, has rejected every one of the policy commission’s assertions. It has run a huge local advertising campaign touting the expansion and sought to burnish its image with full-page ads in The New York Times, which has a wide readership in Boston. “It is important people know the facts, and advertising is just one way to make sure those facts are publicly known and set the record straight from unfounded claims,” Jennifer Street, a spokesperson for MGB, told The Boston Globe

MGB rejected every objection to its planned expansion in a commissioned report submitted to the state agency, whose ruling on the request is imminent. “The predicted changes in Mass General Brigham’s shares associated with the proposed project are modest and unlikely to change the system’s bargaining leverage with health insurers meaningfully,” the report, prepared by the Charles River Associates consulting firm, said. “Rather, the weight of the economics literature suggests that allowing capacity-constrained health care providers such as Massachusetts General Hospital to expand puts downward pressure on health care prices and reduces expenditures on health care services.”

It is a curious assertion, given that the economics literature is equally suggestive of just the opposite. The MGB report gives short shrift to the life’s work of Stanford University’s Victor Fuchs, whose pioneering work since the 1960s has outlined the information asymmetry that drives patients to more expensive care and inhibits competition; the studies, books, and journalism by Atul Gawande from the Dartmouth Atlas of Health Care, which documents how provider-driven supply coupled with physician-induced demand leads to extensive variation in the quantity of health care delivered in different markets; and the voluminous literature on physician-driven demand.

The MGB report also failed to consider the rapidly changing health care marketplace. It projected a steady increase in demand based on the aging of the population. It didn’t mention advances in technology driving surgeries and procedures to outpatient settings or the changing patient preferences for shorter stays and at-home care.

Neither Mass General Brigham nor the Health Policy Commission considered what should go into reconstructing the biggest hospital in Boston. What about flexible facilities to accommodate future pandemics, natural or man-made disasters, or mass casualty events? How can new construction projects better serve residents in low-income neighborhoods in worse health with lagging longevity and poor access to health care facilities? The public debate in Boston—and nationwide—is nonexistent.

I posed that question to Altman of the HPC. “Who’s doing planning for the future? We’ve stopped focusing on that,” he replied. “A number of people are focusing on concentration. But most of the research I see focuses on very different subjects. Planning used to be a very important subject, but it was abandoned in the 1980s. That decision really needs to be reviewed.”

https://washingtonmonthly.com/2022/04/08/is-a-misguided-hospital-building-boom-coming/